Abbas, Y. (2024) “Iraqi Registry Data Proves Safety and Efficacy of switching to Adalimumab Biosimilar in Treating Rheumatoid Arthritis”, AL-Kindy College Medical Journal, 20(3), pp. 216–221. doi:10.47723/2km3dk27.